Sugi Predict

Sugi Predict / Compounds / SCHEMBL17260796

SCHEMBL17260796

SCHEMBL17260796

CC(C)(C)[Si](Oc1ccc2[nH]c(=O)oc2c1)(c1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 1/20 0.44
▸ OGT O15294 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ CREBBP Q92793 1/20 0.41
▸ PDE3B Q13370 1/20 0.40
▸ PDE3A Q14432 1/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CDC7 O00311 1/20 0.38
▸ CCNE1 P24864 1/20 0.38
▸ DBF4 Q9UBU7 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ KDM1A O60341 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ IL4I1 Q96RQ9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6871263 0.85 MAOA (0.55) PDE3BPDE3ASMN1; SMN2MAOAMAOB
SCHEMBL16146346 0.80 IL4I1 (0.44) NOS1OGTPOLBCREBBPPDE3B
SCHEMBL30887675 0.74 RAB9A (0.56) TSHRSMN1; SMN2MAOAMAOBTDP1
Coixol SCHEMBL912220 0.72 NOS1 (0.61) NOS1OGTPOLBCREBBPPDE3B
Coixol SCHEMBL29389732 0.72 NOS1 (0.61) NOS1OGTPOLBCREBBPPDE3B
SCHEMBL16963882 0.71 NOS1 (0.59) NOS1OGTPOLBCREBBPPDE3B
SCHEMBL20357863 0.71 NPC1 (0.43) POLBCA1MAOAMAOBMEN1
SCHEMBL30957317 0.70 CA12 (0.56) NOS1OGTPOLBCREBBPPDE3B
SCHEMBL244105 0.70 CA12 (0.56) NOS1OGTPOLBCREBBPPDE3B
SCHEMBL5062221 0.70 MMP12 (0.40) SMN1; SMN2TDP1ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10226452-B2 Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-03-12 — — US disclosed
US-20170182010-A1 BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2017-06-29 — — US disclosed
WO-2015173168-A1 BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2015-11-19 — — WO disclosed
WO-2015173168-A1 BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) 2015-11-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10226452-B2 Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments ASAH1, ASAH2, ACER2 NOS1 3304/4885OGT 2731/4885POLB 3345/4885
US-20170182010-A1 BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS ASAH1, ASAH2, ACER2 NOS1 3304/4885OGT 2731/4885POLB 3345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.